Rise Therapeutics

Private

#Immunotherapy #Oncology #Autoimmune Disease

Rockville, Maryland-based clinical-stage biotechnology company developing orally delivered, precision-directed synthetic biology medicines that harness dendritic cells to control immune responses in cancer and autoimmune disease.

Company Info

Sector:Biotechnology

Headquarters:Rockville, Maryland, USA

Founded:2016

Website:www.risetherapeutics.com/

Upcoming Milestones & Key Dates

2027

Readout

R-5780 dose-expansion data in cancer patients

Clinical Development Pipeline

R-5780

Target: Dendritic cell-targeted oral immunotherapy

Solid tumors in combination with checkpoint inhibitors

Preclinical

Phase 1

Phase 2

Phase 3

Approved

Leadership Team

Gary Fanger, PhD

Founder, President and Chief Executive Officer

Neil Fanger

Co-Founder

Careers & Job Openings

See all open roles

All departments

Multiple locations

Apply Now →

Rise Therapeutics

Company Info

Upcoming Milestones & Key Dates

Clinical Development Pipeline

R-5780

Recent News